Skip to main content
VCbacked
Log inGet Started

BridGene Biosciences

Sunnyvale, United States

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

$28.0M raised
Oct 2025
Series B
BiotechnologyTherapeutics

Top Investors

Lapam CapitalBayland CapitalProx VenturesGrains Valley Venture CapitalKaitai Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BridGene Biosciences

How much funding has BridGene Biosciences raised?
BridGene Biosciences has raised $28.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
Who are BridGene Biosciences's investors?
BridGene Biosciences's investors include Lapam Capital, Bayland Capital, Prox Ventures, Grains Valley Venture Capital, Kaitai Capital.
Where is BridGene Biosciences headquartered?
BridGene Biosciences is headquartered in Sunnyvale, United States.
What does BridGene Biosciences do?
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
What stage is BridGene Biosciences at?
BridGene Biosciences is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BridGene Biosciences — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/bridgene-biosciences. Accessed June 17, 2026.
APA
VCBacked. (2025). BridGene Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/bridgene-biosciences
Wikipedia (cite web)
{{cite web |title=BridGene Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bridgene-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong